The Neurodiagnostics Report 2010: Brain Imaging, Biomarkers and NeuroInformaticsNeuroInsights, LLCJanuary 15, 2010 109 Pages - SKU: NEI2587677 |
Nearly 2 billion people worldwide and 100 million people in the US are affected by a brain or nervous system disorder including addiction, Alzheimer’s, depression, anxiety, schizophrenia, attention disorders, epilepsy, Parkinson’s disease, sensory disorders, and sleep disorders. Diagnosis of these disorders is rapidly changing as new tools are developed for more objective and personalized assessment and treatment. In addition to the massive unmet markets, long term growth in neurodiagnostics is being driven by 1) technology advances and equipment upgrades in neuroimaging, 2) new biomarkers and imaging protocols for early diagnosis and disease monitoring, and 3) increased use of imaging and informatics in drug and device development. |
Related Markets
- Biotechnology
- Genomics
- Informatics
- Biomarkers
- Diagnostics
- Medical Imaging
- Diseases & Conditions
- Alzheimer's Disease
- Parkinson's Disease
- Therapeutic Area
- CNS/Neurology
CNS/Neurology Reports
- The Neurodiagnostics Report: Brain Imaging, Biomarkers and NeuroInformatics
- The Landscape of Companion Diagnostics: Challenges, Opportunities, and Future Trends
- European Sleep Diagnostics and Associated Data Management Systems
- U.S. CSF Management and Interventional Neuroradiology Markets
- Neurological Trauma Therapeutics: Markets & Developments